Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

CDMO Recro Gainesville Expands Manufacturing Capabilities: New Tableting Equipment

By BusinessWire | May 26, 2017

Recro Gainesville expands manufacturing capabilities with new tableting equipment and growing development team.

Recro Gainesville, LLC, a wholly-owned subsidiary of Recro Pharma, Inc, has expanded its capabilities by adding a new tablet manufacturing suite and growing its development team. An FDA- and DEA-approved leading provider of solid oral dose manufacturing services for the pharmaceutical industry, Recro specializes in extended release and controlled substances.

“As long-term leaders in the development of extended release technology, we pride ourselves in meeting our clients’ exact standards,” said Scott Rizzo, general manager. “By expanding our equipment line and adding nearly a dozen more scientists to our team, we are able to offer yet more services to meet our clients’ needs.”

Specializing in formulation, reformulation, analytical method development, manufacturing and packaging and logistics services, Recro is one of only a few contract manufacturing and development organizations capable of taking delayed release, sustained release or combination release products from development to commercialization.

The company’s new suite includes a state-of-the-art tablet press, the Fette FE 55, and a new film coater, the Bohle BTC-100.

“Our new tablet press will enable us to compress single- and bi-layer tablets at commercial speeds,” Rizzo said. “The new equipment further demonstrates our commitment to remain a leader in the solid dose manufacturing world.”

(Source: BusinessWire)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE